1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Orpha Biotech S.r.l.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2018

Location

Lecce Italy

Primary Industry

Biotechnology

About

Based in Lecce, Italy, and founded in 2018, Orpha Biotech S.r.l. develops solutions for the treatment of rare frequency diseases. In July 2020, the firm raised an amount of seed funding from investor CDP Venture Capital. The company offers innovative solutions which help in the treatment of rare frequency diseases for which the treatment or therapies do not exist. The firm focuses on central molecular determinants and biological mechanisms of disease. Additionally, the firm has developed a platform of small molecules that can be used as a potential agonist or antagonist NCEs for a broad spectrum of pathologies.
Current Investors
CDP Venture Capital

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Healthcare
Website
www.orphabiotech.it
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo